GM-CSF induces tumor cell EMT and stemness.

Slides:



Advertisements
Similar presentations
Quantitative assay of phenotypic markers by direct ELISA
Advertisements

Supplementary Figure 2. Free floating tumorspheres expressed multiple stem cell markers such as CD133, Nestin, Sox2 and Tra1-80, as shown for hypoxic.
Figure S1. qPCR analysis of the EMT markers ZEB2 and SNAI1 in Syndecan-1 and control siRNA transfected MDA-MB-231 and MCF-7 cells reveals no significant.
A B C D Figure S3: DiO6(3) staining of mitochondrial networks in primary prostate tumor organ cultures. (A) Epithelial.
WNT5A is a Key Regulator of the Epithelial-Mesenchymal Transition and Cancer Stem Cell Properties in Human Gastric Carcinoma Cells Pathobiology 2013;80:
LUIGI BOURLOT ELENA GALLO
Vascular Endothelial–Cadherin Tyrosine Phosphorylation in Angiogenic and Quiescent Adult Tissues by Nathalie Lambeng, Yann Wallez, Christine Rampon, Francine.
Immunotherapy with Dendritic Cells Modified with Tumor-Associated Antigen Gene Demonstrates Enhanced Antitumor Effect Against Lung Cancer  Tao Jiang,
by JoAnn Castelli, Elaine K
The Chemokine Receptor CXCR4 and c-MET Cooperatively Promote Epithelial- Mesenchymal Transition in Gastric Cancer Cells  Yu Cheng, Yongxi Song, Jinglei.
DEAR1 is a negative regulator of TGF-β–induced migration and EMT
Inhibition of ILK restores epithelial ZO-1 and E-cadherin and inhibits fibronectin and Snail1 expression after TGF-β1 treatment. Inhibition of ILK restores.
25(OH)D and 1,25(OH)2D perfusion treatment effect on cancer-related markers: IF stains illustrating expression levels for Ki-67 (A), cyclin D1 (B), ErbB-2.
Identifying Inhibitors of Epithelial-Mesenchymal Transition by Connectivity Map–Based Systems Approach  Ajaya Kumar Reka, PhD, Rork Kuick, MS, Himabindu.
Molecular Therapy - Nucleic Acids
Volume 133, Issue 4, Pages (May 2008)
XL184 effects on RIP-Tag2 tumor invasion and epithelial/mesenchymal markers. XL184 effects on RIP-Tag2 tumor invasion and epithelial/mesenchymal markers.
Volume 138, Issue 4, Pages (August 2009)
Tregs and APC subsets in TDLNs of patients with cervical cancer.
Fig. 7. Altering GUCD1 expression reversed the effect of miR-370 on cell EMT process in HCC. (A) Western blot and (B) qRT-PCR results showed that GUCD1overexpression.
Cytotoxic therapy induces CSF1-dependent macrophage recruitment.
AG-221 can reduce intracellular 2HG levels and induce differentiation in primary human IDH2R140Q- or IDH2R172K-mutant AML patient samples treated ex vivo.
Fig. 4. miR-370 restoration suppressed EMT progression in HCC cells
BIRC6 is expressed in the tumorigenic Aldefluorhigh fraction of colonosphere cells. BIRC6 is expressed in the tumorigenic Aldefluorhigh fraction of colonosphere.
Downregulation of SPRY4 expression is associated with FGFR1–FRS2 activation. Downregulation of SPRY4 expression is associated with FGFR1–FRS2 activation.
Volume 138, Issue 4, Pages (April 2010)
Collagen-dependent phosphorylation of eIF4E in PDAC cells.
Figure 1. The activity of CD26/DPP4 in patient samples with lung adenocarcinoma. The measured activity is presented by ... Figure 1. The activity of CD26/DPP4.
Volume 138, Issue 4, Pages (August 2009)
HJURP is required for CENP-A localization to centromeres.
Sorafenib inhibits growth, migration, and angiogenic potential of ectopic endometrial mesenchymal stem cells derived from patients with endometriosis 
Effects of Z-FA-FMK on SMN protein expression in type II SMA patient fibroblast cells (GM22592). Effects of Z-FA-FMK on SMN protein expression in type.
(fold of TGF-β1 response)
VIP treatment decreased the number of apoptotic cells and increased cell proliferation. VIP treatment decreased the number of apoptotic cells and increased.
CPI-444 efficacy requires CD8+ T cells and is associated with increased CD73 expression. CPI-444 efficacy requires CD8+ T cells and is associated with.
Effects of PS-341 on apoptosis in orthotopic human pancreatic tumors.
a b 10A.zp85WT 10A.zp85S83μ 10A.vec 10A.z 10A.vec 10Az 10Az.p85WT
CD49b+ cells from tumor-bearing mice are more prone to conversion into MDSCs compared with naive CD49b+ cells. CD49b+ cells from tumor-bearing mice are.
CD11bhighCD27high conventional NK cells are converted into MDSCs
MMP-1 functionally contributes to HEp3-hi/diss intravasation and metastasis. MMP-1 functionally contributes to HEp3-hi/diss intravasation and metastasis.
TGF-β1 modulates extracellular matrix–mediated MT1-MMP expression.
Depletion of HDAC2 sensitizes cells to epirubicin-induced apoptosis.
Effects of visfatin on the cell proliferation and phosphorylation of ERK, Akt, and GSK-3β proteins in HCC cells. Effects of visfatin on the cell proliferation.
Expression of CRC stem cell markers and L1 in CRC cells.
Ki-67 expression in M31- and H3-treated tumors (A) and respective Ki-67 labeling indices in the two groups of tumors (B). Ki-67 expression in M31- and.
GM-CSF is required for CA-MSC–induced tumor metastasis.
CA-MSCs differentially secrete GM-CSF.
The effects of HDAC2 knockdown on cell-cycle proteins.
The combination of trastuzumab and SU11274 abrogate Akt phosphorylation. The combination of trastuzumab and SU11274 abrogate Akt phosphorylation. Serum-starved.
FGFR1 is dominantly expressed in mesenchymal-like KRAS-mutant lung cancer cell lines. FGFR1 is dominantly expressed in mesenchymal-like KRAS-mutant lung.
Expression of HO-1 by the FAP+/F4/80+ tumoral macrophages.
Combined inhibition of coamplified RTKs is required for response.
Increased frequency and number of KLL-specific clonotypes in tumors is associated with improved MCC-specific survival. Increased frequency and number of.
CD24 expression. CD24 expression. A, By global gene expression, CD24 is found to be highly upregulated in SEF (80×) and in LGFMS (37×) as compared with.
CHL-induced apoptosis in HCT116 cells involves the activation of procaspase-8 and procaspase-6, with cleavage of nuclear lamins. CHL-induced apoptosis.
Double knockdown of HER2/EGFR abolishes HPSE nucleolar localization in 231BR3 cells. Double knockdown of HER2/EGFR abolishes HPSE nucleolar localization.
Effect of MIF siRNA on the production of MMP-13 induced by LPA
RA-9 induces G2–M cell-cycle arrest and caspase-mediated apoptosis in ovarian cancer cells. RA-9 induces G2–M cell-cycle arrest and caspase-mediated apoptosis.
LY elicits hyperphosphorylation of Akt.
Establishment and characterization of primary CAFs from patients with colorectal cancer. Establishment and characterization of primary CAFs from patients.
GCS-100 selectively kills KRAS-addicted lung tumors.
Induction of PD-1 in B cells by TLR agonists and primary HCC-SN.
Elevated STAT3 phosphorylation and RANTES levels in tamoxifen-treated breast cancer cells. Elevated STAT3 phosphorylation and RANTES levels in tamoxifen-treated.
EGF induces HPSE nucleolar localization in human BMBC cells.
Coculture with U937 cells enhances DNMT1 expression in gastric cancer cells. Coculture with U937 cells enhances DNMT1 expression in gastric cancer cells.
Recruitment of CD8+, CD4+, and Foxp3+ cells into oral lesions in response to anti–PD-1 treatment. Recruitment of CD8+, CD4+, and Foxp3+ cells into oral.
MSCs elicit EMT, invasion of carcinoma cells, and increased tumor initiation of xenografts. MSCs elicit EMT, invasion of carcinoma cells, and increased.
Effects of inhibitors of PI3K, MEK1, and GSK-3β on visfatin-induced proliferation in HepG2 cells. Effects of inhibitors of PI3K, MEK1, and GSK-3β on visfatin-induced.
TAMs upregulate DNMT1 in gastric cancer cells through the CCL5/CCR5/STAT3 pathway. TAMs upregulate DNMT1 in gastric cancer cells through the CCL5/CCR5/STAT3.
Knockdown of ROR1 increases the invasive potential of melanoma cells in vitro and in vivo. Knockdown of ROR1 increases the invasive potential of melanoma.
Presentation transcript:

GM-CSF induces tumor cell EMT and stemness. GM-CSF induces tumor cell EMT and stemness. A, IHC staining of UM5 tumor cells for the epithelial marker E-cadherin and mesenchymal marker vimentin following treatment with exogenous GM-CSF (100 ng/mL). B, Western blotting for EMT markers and phosphorylated (p) and total STAT3 in the UM5, UM2, and UM8 pancreatic cancer cells treated with exogenous GM-CSF. C, Western blot evaluating expression of EMT markers in either control or STAT3 siRNA (1 and 2) UM5 cells treated with GM-CSF. D, enhanced size of tumorspheres when UM5, UM2, and UM8 tumor cells were treated with 100 ng/mL GM-CSF (*, P < 0.0001 vs. control for UM5; *, P < 0.0001 vs. control for UM2; *, P < 0.004 vs. control for UM8). E, FACS analysis revealed an increase in the percentage of CSCs (ESA+CD44+CD24+) when cultured in the presence of exogenous GM-CSF (100 ng/mL; *, P < 0.05 vs. control for UM5; *, P < 0.02 vs. control for UM2; *, P < 0.0001 vs. control for UM8). F, FACS analysis for CSF2Ra receptor expression in CSCs (green) and bulk cells (red) showing significantly higher number of CSCs (green) expressing GM-CSF receptor than the bulk tumor cell population (red). Meghna Waghray et al. Cancer Discov 2016;6:886-899 ©2016 by American Association for Cancer Research